ZNF318 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.403000E-01
Normal-vs-Stage2
4.060600E-01
Normal-vs-Stage3
3.343800E-01
Normal-vs-Stage4
4.477600E-01
Stage1-vs-Stage2
5.129200E-01
Stage1-vs-Stage3
5.277900E-02
Stage1-vs-Stage4
9.337600E-01
Stage2-vs-Stage3
5.78420000008073E-07
Stage2-vs-Stage4
5.221800E-01
Stage3-vs-Stage4
1.116640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.117800E-01
Normal-vs-AfricanAmerican
4.217800E-01
Normal-vs-Asian
3.598800E-01
Caucasian-vs-AfricanAmerican
8.600200E-01
Caucasian-vs-Asian
1.182610E-01
AfricanAmerican-vs-Asian
1.004950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.031800E-01
Normal-vs-Female
4.173600E-01
Male-vs-Female
4.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.024800E-01
Normal-vs-Age(41-60Yrs)
4.249000E-01
Normal-vs-Age(61-80Yrs)
4.010000E-01
Normal-vs-Age(81-100Yrs)
4.188200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.997800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.958400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.999200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.153600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.343600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.460200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.950800E-01
Normal-vs-Daily Drinker
3.672800E-01
Normal-vs-Weekly Drinker
3.832200E-01
Normal-vs-Occasional Drinker
4.396200E-01
Normal-vs-Social Drinker
4.202400E-01
Non Drinker-vs-Daily Drinker
3.352200E-01
Non Drinker-vs-Weekly Drinker
6.766200E-01
Non Drinker-vs-Occasional Drinker
2.691600E-01
Non Drinker-vs-Social Drinker
5.200400E-01
Daily Drinker-vs-Weekly Drinker
5.244200E-01
Daily Drinker-vs-Occasional Drinker
5.977500E-02
Daily Drinker-vs-Social Drinker
1.077170E-01
Weekly Drinker-vs-Occasional Drinker
1.475190E-01
Weekly Drinker-vs-Social Drinker
3.056600E-01
Occasional Drinker-vs-Social Drinker
6.854400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.624400E-01
Normal-vs-Grade 2
1.272770E-01
Normal-vs-Grade 3
8.172000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.551400E-01
Grade 1-vs-Grade 3
4.320800E-01
Grade 1-vs-Grade 4
2.624400E-01
Grade 2-vs-Grade 3
5.064600E-01
Grade 2-vs-Grade 4
1.272770E-01
Grade 3-vs-Grade 4
8.172000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.030000E-01
Normal-vs-NonDiabetic
3.968800E-01
Diabetic-vs-NonDiabetic
7.617400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.687400E-01
Normal-vs-NoPancreatitis
4.023000E-01
Pancreatitis-vs-NoPancreatitis
8.776100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.160600E-01
Normal-vs-N1
4.065800E-01
N0-vs-N1
6.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.625000E-01
Normal-vs-TP53-NonMutant
4.425400E-01
TP53-Mutant-vs-TP53-NonMutant
1.157140E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
